SUBSTITUIERTE OXOAZAHETEROCYCLYL FAKTOR XA HEMMER

This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inh...

Full description

Saved in:
Bibliographic Details
Main Authors LAU, WAN, F, PAULS, HEINZ, W, LI, AIWEN, POLI, GREGORY, B, MYERS, MICHAEL, R, CONDON, STEPHEN, M, HANNEY, BARBARA, A, JIANG, JOHN, Z, EWING, WILLIAM, R, HE, WEI, DAVIS, RODERICK, S, BECKER, MICHAEL, R, SPADA, ALFRED, P, CHOI-SLEDESKI, YONG, MI, BURNS, CHRISTOPHER, J
Format Patent
LanguageGerman
Published 15.12.2006
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa.
Bibliography:Application Number: AT19990906684T